0 Yorumlar
0 hisse senetleri
119 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Epidermal Growth Factor Receptor Inhibitor Market Growth Drivers and Investment OpportunitiesThe global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...0 Yorumlar 0 hisse senetleri 999 Views 0 önizleme
-
Global Dual-Antibody ADC Market Growing at 6.2% CAGR Through 2032According to a new report from Intel Market Research, the global Dual-Antibody ADC market was valued at USD 477 million in 2024 and is projected to reach USD 691 million by 2032, exhibiting a steady CAGR of 6.2% during the forecast period (2025–2032). This growth is driven by increasing cancer prevalence and demand for precision medicine, superior tumor targeting capabilities of...0 Yorumlar 0 hisse senetleri 593 Views 0 önizleme
-
HDAC Inhibitor Market Segmentation Analysis by Indication and End UserThe global HDAC inhibitor market is gaining significant momentum as the healthcare industry continues to advance targeted therapies for cancer and other complex diseases. Histone deacetylase (HDAC) inhibitors are a class of compounds that regulate gene expression by altering chromatin structure, making them valuable in the treatment of various malignancies and epigenetic disorders. The...0 Yorumlar 0 hisse senetleri 937 Views 0 önizleme
-
Lymphoma Treatment Market Growth Potential Driven by Advances in Cancer TherapeuticsThe lymphoma treatment market is witnessing significant growth as healthcare providers increasingly focus on improving outcomes for patients diagnosed with Hodgkin lymphoma and non-Hodgkin lymphoma. Rising cancer prevalence, advancements in oncology research, and the growing adoption of innovative treatment approaches are contributing to the expansion of the market. The development of targeted...0 Yorumlar 0 hisse senetleri 911 Views 0 önizleme
-
Rare Neurological Disease Treatment Market Competitive Landscape and Key PlayersThe global rare neurological disease treatment market is witnessing substantial growth due to increasing awareness regarding rare neurological disorders, rising investments in orphan drug development, and rapid advancements in biotechnology and precision medicine. Rare neurological diseases are complex disorders that affect the brain, spinal cord, nerves, and muscles, often leading to severe...0 Yorumlar 0 hisse senetleri 731 Views 0 önizleme
-
United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...0 Yorumlar 0 hisse senetleri 847 Views 0 önizleme
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek